Injective (INJ) price is extending gains above the $10 mark, currently trading above $13.60 driven by Bitcoin's rally above $105,000 and real-world asset tokenization catalysts.
Injective is among the top-performing altcoins as bullish momentum sweeps through the market, with increased speculative interest in projects like Injective due to macroeconomic optimism and regulatory progress.
INJ technical outlook is largely bullish, with the daily RSI indicating potential for more gains, and the MACD showing a bullish crossover, targeting levels around $16 and $20 if the momentum continues.
Injective's focus on decentralised finance and real-world asset tokenization, coupled with strong institutional demand and the growth of the RWA ecosystem, may further boost INJ's price momentum in the near term.